IRIS
PERRICONE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 58.748
AS - Asia 6.630
EU - Europa 5.833
SA - Sud America 844
AF - Africa 131
OC - Oceania 97
Continente sconosciuto - Info sul continente non disponibili 10
Totale 72.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 58.511
SG - Singapore 3.089
CN - Cina 1.464
DE - Germania 834
RU - Federazione Russa 815
IT - Italia 770
BR - Brasile 719
UA - Ucraina 700
FR - Francia 598
IE - Irlanda 588
HK - Hong Kong 577
FI - Finlandia 511
VN - Vietnam 480
GB - Regno Unito 347
SE - Svezia 254
JP - Giappone 177
BD - Bangladesh 174
KR - Corea 169
CA - Canada 131
IN - India 108
PL - Polonia 76
NL - Olanda 74
BE - Belgio 64
MX - Messico 61
AU - Australia 53
ID - Indonesia 47
ES - Italia 45
NZ - Nuova Zelanda 43
TW - Taiwan 42
ZA - Sudafrica 42
AR - Argentina 39
DK - Danimarca 36
IQ - Iraq 36
UZ - Uzbekistan 35
TR - Turchia 31
IR - Iran 30
PK - Pakistan 28
MY - Malesia 24
EC - Ecuador 23
SA - Arabia Saudita 23
AT - Austria 20
EG - Egitto 19
MA - Marocco 19
PH - Filippine 19
LT - Lituania 16
AE - Emirati Arabi Uniti 15
CO - Colombia 15
CL - Cile 13
RO - Romania 13
LV - Lettonia 11
CZ - Repubblica Ceca 10
KE - Kenya 10
TN - Tunisia 10
VE - Venezuela 10
ET - Etiopia 8
GR - Grecia 8
IL - Israele 8
NP - Nepal 8
PE - Perù 8
JM - Giamaica 7
KG - Kirghizistan 7
UY - Uruguay 7
DZ - Algeria 6
HU - Ungheria 6
JO - Giordania 6
PY - Paraguay 6
BG - Bulgaria 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
HN - Honduras 5
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
CH - Svizzera 4
EU - Europa 4
GH - Ghana 4
NI - Nicaragua 4
OM - Oman 4
SV - El Salvador 4
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
GT - Guatemala 3
MD - Moldavia 3
NO - Norvegia 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GA - Gabon 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
Totale 72.271
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.549
Wilmington 15.053
Houston 13.916
Singapore 1.635
Fairfield 1.633
Ann Arbor 1.432
Ashburn 1.098
Chandler 1.084
San Jose 654
Seattle 650
Jacksonville 596
Hong Kong 568
Cambridge 540
Dublin 512
Beijing 472
Medford 421
New York 394
Helsinki 368
Dallas 310
The Dalles 301
Santa Clara 274
Los Angeles 250
Lawrence 195
Rome 195
Dearborn 192
Council Bluffs 189
Lauterbourg 147
Ho Chi Minh City 135
Moscow 135
Zhengzhou 124
Hanoi 117
Tokyo 107
Buffalo 94
Chicago 85
São Paulo 84
Menlo Park 79
San Diego 77
Boardman 74
Mülheim 71
Redwood City 70
Milan 67
London 62
Munich 54
Nanjing 53
Brussels 51
Toronto 47
Shanghai 46
Tauranga 42
Falls Church 41
Norwalk 41
Palo Alto 39
Seoul 39
Orem 37
Phoenix 37
Kraków 36
Nuremberg 36
Redondo Beach 35
Copenhagen 34
Amsterdam 33
Stockholm 32
Warsaw 31
Chester 30
Johannesburg 30
Mountain View 30
Atlanta 29
Columbus 29
Guangzhou 29
Hefei 29
Verona 29
Frankfurt am Main 28
Shenzhen 28
Denver 27
Kunming 27
Chengdu 26
Jakarta 26
San Mateo 26
Brooklyn 25
Melbourne 25
Montreal 24
Suzhou 24
University Park 24
Haiphong 22
Taipei 22
Chennai 21
North Bergen 21
San Francisco 21
Chongqing 20
Boston 19
Rio de Janeiro 19
Baghdad 17
Dong Ket 16
Naples 16
Augusta 15
Da Nang 15
Belo Horizonte 14
Curitiba 14
Jeddah 14
Porto Alegre 14
Brasília 13
Jinan 13
Totale 61.644
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 855
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis 562
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 562
Complement, infection, and autoimmunity 544
Complement and autoimmunity 530
Gonadal mosaicism in hereditary angioedema 529
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 516
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 515
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 514
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 510
Autoantibodies in inflammatory arthritis 509
NK cells in autoimmunity: A two-edg'd weapon of the immune system 508
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 505
Vasculitides and the Complement System: a Comprehensive Review 503
Serum thymosin alpha 1 levels in normal and pathological conditions 502
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 498
Glutathione: A key player in autoimmunity 497
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 491
Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission? 487
Denaturing HPLC in laboratory diagnosis of hereditary angioedema 486
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 485
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 484
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 483
Evidence of impaired sense of smell in hereditary angioedema 483
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 482
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 482
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 478
Apremilast for the treatment of psoriasis. 477
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 475
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 474
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 472
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 470
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 467
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 467
The type I IFN system in rheumatoid arthritis 464
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 463
High-dose intravenous immunoglobulin treatment activates complement in vivo 462
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 462
Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis 461
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 460
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 457
Complement activation and sensitizing antibodies in lyme borreliosis - a microbial adherence immobilization assay for borrelia-burgdorferi (maia-bb) 456
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 456
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 456
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 455
Adalimumab and polymyalgia rheumatica. clinical remission but persisting high levels of esr: a controversy 455
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 455
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 453
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity 452
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 450
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 450
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 449
The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies 448
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. 447
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 445
The European register of hereditary angioedema: Experience and preliminary results 441
Antimyocardial Autoantibodies (AMCA) 440
GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment 438
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: The experience of two Italian integrated Dermatology/Rheumatology outpatient clinics 438
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 438
HELLP syndrome: A complication or a new autoimmune syndrome? 438
Occurrence of localized scleroderma morphea in a patient with rheumatoid arthritis treated with etanercept 437
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 435
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group 435
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 431
Auto-reactions, autoimmunity and psoriatic arthritis 431
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 430
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab 430
European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT 429
Behcet's disease and etanercept: eighty weeks of experience 428
Cytokine production by human fetal membranes and uterine decidua at term gestation in relation to labor 428
Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. 427
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 427
ADA genetic polymorphism and total plasma IgE level in healthy adults 426
Small-medium vessel vasculitides: Is the complement system a potential forgotten target? 423
TREATMENT OF RECURRENT SPONTANEOUS ABORTION WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN 422
Cystic ovaries in women affected with hereditary angioedema. 422
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 421
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 420
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 420
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 420
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 419
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways 416
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 416
BETA ENDORPHIN INTERACTION WITH LFA 1 (CD11A/CD18) ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES 415
The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency 415
Successful high dose intravenous immunoglobulin treatment of a pregnant patient affected with hypereosinophilia syndrome and antiphospholipid syndrome (aPL plus recurrent spontaneous abortion) 414
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 414
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication 414
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 413
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 412
NK cells, autoantibodies, and immunologic infertility: a complex interplay 411
Insights on the role of physical activity in patients with rheumatoid arthritis 411
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 410
The interplay between inflammation and metabolism in rheumatoid arthritis 410
Discontinuation of anti-TNFα therapy due to remission in rheumatoid arthritis: A retrospective study 410
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 409
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 406
Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy 406
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects 404
Totale 45.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 0 97
2021/20222.080 108 221 157 118 84 128 101 99 101 198 180 585
2022/20232.649 239 229 97 368 252 581 204 162 264 38 153 62
2023/20241.026 132 41 48 35 84 317 29 106 19 26 16 173
2024/20254.597 181 980 493 273 105 304 214 181 436 412 581 437
2025/20268.626 592 335 1.086 824 814 384 1.207 939 868 780 433 364
Totale 73.032